Carvedilol versus metoprolol, but which metoprolol?: Effect on inappropriate cardioverter-defibrillator therapy

Journal of the American College of Cardiology

Volumn 63, Issue 18, 2014, Pages 1933-

  Whayne, Thomas F ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARVEDILOL; METOPROLOL TARTRATE; METOPROLOL SUCCINATE;

COMPARATIVE EFFECTIVENESS; DRUG USE; HEART FAILURE; LETTER; MORTALITY; PRIORITY JOURNAL; DEFIBRILLATION; DRUG EFFICACY; HUMAN; INAPPROPRIATE PRESCRIBING; RANDOMIZED CONTROLLED TRIAL (TOPIC);

CARBAZOLES; CARDIAC RESYNCHRONIZATION THERAPY; DEFIBRILLATORS, IMPLANTABLE; FEMALE; HEART FAILURE; HUMANS; MALE; METOPROLOL; PROPANOLAMINES;

EID: 84899826281     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2013.11.042     Document Type: Letter

References (4)

1. M.H. Ruwald, A. Abu-Zeitone, and C. Jons et al. Impact of carvedilol and metoprolol on inappropriate implantable cardioverter-defibrillator therapy: THe MADIT-CRT Trial (Multicenter Automatic Defibrillator Implantation With Cardiac Resynchronization Therapy) J Am Coll Cardiol 62 2013 1343 1350
2. M.H. Raitt Inappropriate implantable defibrillator shocks: an adverse outcome that can be prevented J Am Coll Cardiol 62 2013 1351 1352
3. Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF) Lancet 353 1999 2001 2007
4. P.A. Poole-Wilson, K. Swedberg, and J.G. Cleland et al. Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET): randomised controlled trial Lancet 362 2003 7 13